Trematocine-derived antimicrobial peptides from the Antarctic fish Trematomus bernacchaii: potent antibacterial agents against ESKAPE pathogens
This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid...
Saved in:
Published in | Frontiers in microbiology Vol. 15; p. 1447301 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
07.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish
, aiming to increase their positive charge.
The selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE (
, and
family) pathogens for both Trem-HK and Trem-HSK.
Firstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their α-helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations.
Assessment of
toxicity using the
model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for
, suggesting a high potential safety profile for the mutants. This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs. |
---|---|
AbstractList | This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish Trematomus bernacchii, aiming to increase their positive charge.IntroductionThis study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish Trematomus bernacchii, aiming to increase their positive charge.The selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae family) pathogens for both Trem-HK and Trem-HSK.MethodsThe selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae family) pathogens for both Trem-HK and Trem-HSK.Firstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their α-helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations.ResultsFirstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their α-helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations.Assessment of in vivo toxicity using the Galleria mellonella model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for Acinetobacter baumannii, suggesting a high potential safety profile for the mutants. This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs.DiscussionAssessment of in vivo toxicity using the Galleria mellonella model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for Acinetobacter baumannii, suggesting a high potential safety profile for the mutants. This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs. This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish , aiming to increase their positive charge. The selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE ( , and family) pathogens for both Trem-HK and Trem-HSK. Firstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their α-helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations. Assessment of toxicity using the model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for , suggesting a high potential safety profile for the mutants. This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs. IntroductionThis study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish Trematomus bernacchii, aiming to increase their positive charge.MethodsThe selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae family) pathogens for both Trem-HK and Trem-HSK.ResultsFirstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their α-helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations.DiscussionAssessment of in vivo toxicity using the Galleria mellonella model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for Acinetobacter baumannii, suggesting a high potential safety profile for the mutants. This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs. |
Author | Squitieri, Damiano Cacaci, Margherita Buonocore, Francesco Ceccacci, Francesca Porcelli, Fernando Borocci, Stefano Graziano, Monica Mollica Massaro, Federica Sanguinetti, Maurizio Rosato, Roberto Bugli, Francesca Di Vito, Maura |
AuthorAffiliation | 1 Department of Basic Biotechnological Sciences, Intensive and Perioperative Clinics, Catholic University of the Sacred Heart , Rome , Italy 2 Department for Innovation in Biological, Agro-Food and Forest Systems (DIBAF), University of Tuscia , Viterbo , Italy 4 Department of Laboratory Sciences and Infectious Diseases, A. Gemelli University Hospital Foundation IRCCS , Rome , Italy 3 Institute for Biological Systems of Italian National Research Council (ISB-CNR), Secondary Office of Rome-Reaction Mechanisms c/o Department of Chemistry, La Sapienza University of Rome , Rome , Italy |
AuthorAffiliation_xml | – name: 1 Department of Basic Biotechnological Sciences, Intensive and Perioperative Clinics, Catholic University of the Sacred Heart , Rome , Italy – name: 4 Department of Laboratory Sciences and Infectious Diseases, A. Gemelli University Hospital Foundation IRCCS , Rome , Italy – name: 3 Institute for Biological Systems of Italian National Research Council (ISB-CNR), Secondary Office of Rome-Reaction Mechanisms c/o Department of Chemistry, La Sapienza University of Rome , Rome , Italy – name: 2 Department for Innovation in Biological, Agro-Food and Forest Systems (DIBAF), University of Tuscia , Viterbo , Italy |
Author_xml | – sequence: 1 givenname: Damiano surname: Squitieri fullname: Squitieri, Damiano – sequence: 2 givenname: Federica surname: Massaro fullname: Massaro, Federica – sequence: 3 givenname: Monica Mollica surname: Graziano fullname: Graziano, Monica Mollica – sequence: 4 givenname: Stefano surname: Borocci fullname: Borocci, Stefano – sequence: 5 givenname: Margherita surname: Cacaci fullname: Cacaci, Margherita – sequence: 6 givenname: Maura surname: Di Vito fullname: Di Vito, Maura – sequence: 7 givenname: Fernando surname: Porcelli fullname: Porcelli, Fernando – sequence: 8 givenname: Roberto surname: Rosato fullname: Rosato, Roberto – sequence: 9 givenname: Francesca surname: Ceccacci fullname: Ceccacci, Francesca – sequence: 10 givenname: Maurizio surname: Sanguinetti fullname: Sanguinetti, Maurizio – sequence: 11 givenname: Francesco surname: Buonocore fullname: Buonocore, Francesco – sequence: 12 givenname: Francesca surname: Bugli fullname: Bugli, Francesca |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39171261$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1u1DAQxyNUREvpC3BAPnLZxY6dxOGCVtUCFZVAokjcrIk93rhK4mB7K_UpeGW8H1QtB3zwWOP__MbjmZfFyeQnLIrXjC45l-07OzrdLUtaiiUTouGUPSvOWF2LBaflz5NH59PiIsZbmpegZd5fFKe8ZQ0ra3ZW_L4JOELy2k24MBjcHRoCU3IZH3znYCAzzskZjMQGP5LUI1lNCYJOThPrYk-OiHEbSYdhAq17cO49mX3CKe1pHeiU4ZkGm-yL2YCbYiLr719W39ZkhtT7fBNfFc8tDBEvjva8-PFxfXP5eXH99dPV5ep6oUXdpgVKgK7T0lhTN4JykLKSLec2e01j68rkT6pLLWtdNqLSbVfWutGCImN1hS0_L64OXOPhVs3BjRDulQen9g4fNgpCrnBARbFCQMltW2kBVndGCkPB0lbyTgPNrA8H1rztRjQ6FxhgeAJ9ejO5Xm38nWKM86qWVSa8PRKC_7XFmNToosZhgAn9NipO26xjtJJZ-uZxsocsf1uaBeVBkPsXY0D7IGFU7UZH7UdH7UZHHUcnB8l_grRLkJzfPdgN_wv9A4uezrI |
CitedBy_id | crossref_primary_10_1016_j_micpath_2025_107361 |
Cites_doi | 10.1128/spectrum.04385-22 10.3109/02713688609015126 10.3389/fmicb.2022.1039687 10.1128/CMR.00181-19 10.1002/pep2.24122 10.1007/978-0-387-46312-4 10.1007/978-1-4419-6327-7_2 10.3390/ijms21197047 10.1007/s12551-021-00784-y 10.1016/j.micres.2022.127152 10.1007/s00249-010-0661-4 10.1080/22221751.2022.2030196 10.1021/acsami.2c05979 10.1128/AAC.02097-16 10.1016/S2468-2667(22)00225-0 10.2147/IDR.S428103 10.1016/j.dci.2019.02.012 10.4103/joacp.JOACP_349_15 10.1016/j.ejps.2022.106363 10.1099/acmi.ac2021.po0053 10.1016/j.micpath.2021.105040 10.1016/S1473-3099(20)30327-3 10.1021/acsabm.3c00824 10.3389/fimmu.2023.1168517 10.4161/viru.24930 10.3390/molecules27092675 10.3389/fcimb.2020.540898 10.3389/fcimb.2022.823684 10.1016/S0014-5793(01)02648-5 10.3390/antibiotics9020066 10.1128/mSphere.00775-20 10.1016/j.bbamem.2023.184260 10.1093/jac/dkq037 10.1016/S0140-6736(21)02724-0 10.1002/prot.23188 10.1016/j.ejmech.2023.116072 |
ContentType | Journal Article |
Copyright | Copyright © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli. Copyright © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli. 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli |
Copyright_xml | – notice: Copyright © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli. – notice: Copyright © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli. 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fmicb.2024.1447301 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Open Access Journals (DOAJ) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-302X |
ExternalDocumentID | oai_doaj_org_article_0e5eae83f95c4afcbd84d0af0983bca0 PMC11335685 39171261 10_3389_fmicb_2024_1447301 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK ECGQY GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 PGMZT RNS RPM IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c469t-e8aabbc8dfd67403a8858933fabbd7f65d33862c86c2745c9b26c7c40e1165e93 |
IEDL.DBID | M48 |
ISSN | 1664-302X |
IngestDate | Wed Aug 27 01:32:00 EDT 2025 Thu Aug 21 18:34:48 EDT 2025 Fri Jul 11 04:19:38 EDT 2025 Mon Jul 21 05:55:57 EDT 2025 Thu Apr 24 22:59:53 EDT 2025 Tue Jul 01 02:19:05 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | membranolytic agents ESKAPE pathogens antimicrobial resistance antimicrobial peptides multi-drug resistant bacteria |
Language | English |
License | Copyright © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, Sanguinetti, Buonocore and Bugli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c469t-e8aabbc8dfd67403a8858933fabbd7f65d33862c86c2745c9b26c7c40e1165e93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors share last authorship These authors have contributed equally to this work and share first authorship Edited by: Yovani Marrero-Ponce, University of Valencia, Spain Reviewed by: Dexi Li, Henan Agricultural University, China Ruoyu Mao, Chinese Academy of Agricultural Sciences, China |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fmicb.2024.1447301 |
PMID | 39171261 |
PQID | 3095681058 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_0e5eae83f95c4afcbd84d0af0983bca0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11335685 proquest_miscellaneous_3095681058 pubmed_primary_39171261 crossref_primary_10_3389_fmicb_2024_1447301 crossref_citationtrail_10_3389_fmicb_2024_1447301 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-08-07 |
PublicationDateYYYYMMDD | 2024-08-07 |
PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in microbiology |
PublicationTitleAlternate | Front Microbiol |
PublicationYear | 2024 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | ref13 Schäfer (ref35) 2020; 10 ref14 Loh (ref24) 2013; 4 Shields (ref37) 2017; 61 Browne (ref4) 2020; 21 Hussain (ref17) 2021; 158 Jean (ref18) 2022; 12 O’Neill (ref32) 2016 Luo (ref26) 2023; 181 Kapoor (ref20) 2017; 33 Buonocore (ref6) 2019; 96 Della Pelle (ref11) 2020; 9 Abebe (ref1) 2023; 16 Ayobami (ref3) 2022; 11 Koo (ref21) 2019; 111 Niu (ref31) 2020; 5 Di Vito (ref12) 2023; 11 Garcia Maset (ref16) 2022; 14 Lakowicz (ref22) 2006 Chen (ref8) 2023; 14 Straus (ref38) 2024; 1866 Cardoso (ref7) 2021; 13 Wimley (ref40) 2010; 677 Schwarz (ref36) 2010; 65 Murray (ref30) 2022; 399 Dathe (ref9) 2001; 501 Louis-Jeune (ref25) 2012; 80 Phillips (ref34) 1986; 5 Li (ref23) 2022; 27 Pandey (ref33) 2023; 13 (ref39) 2024 Freire (ref15) 2011; 40 Mba (ref28) 2022; 4 De Oliveira (ref10) 2020; 33 Bugli (ref5) 2022; 263 Alfred (ref2) 2024; 7 Magana (ref27) 2020; 20 Mestrovic (ref29) 2022; 7 Ji (ref19) 2024; 265 |
References_xml | – volume: 11 start-page: e0438522 year: 2023 ident: ref12 article-title: A new potential resource in the fight against Candida auris: the Cinnamomum zeylanicum essential oil in synergy with antifungal drug publication-title: Microbiol. Spectr. doi: 10.1128/spectrum.04385-22 – volume: 5 start-page: 611 year: 1986 ident: ref34 article-title: Acrylamide and iodide fluorescence quenching as a structural probe of tryptophan microenvironment in bovine lens crystallins publication-title: Curr. Eye Res. doi: 10.3109/02713688609015126 – volume: 13 start-page: 13 year: 2023 ident: ref33 article-title: β-LacFamPred: An online tool for prediction and classification of β-lactamase class, subclass, and family publication-title: Front. Microbiol. doi: 10.3389/fmicb.2022.1039687 – volume: 33 start-page: e00181-19 year: 2020 ident: ref10 article-title: Antimicrobial resistance in ESKAPE pathogens publication-title: Clin. Microbiol. Rev. doi: 10.1128/CMR.00181-19 – volume: 111 start-page: e24122 year: 2019 ident: ref21 article-title: Antimicrobial peptides under clinical investigation publication-title: Peptide Sci. doi: 10.1002/pep2.24122 – start-page: 1 volume-title: Principles of fluorescence spectroscopy year: 2006 ident: ref22 doi: 10.1007/978-0-387-46312-4 – volume: 677 start-page: 14 year: 2010 ident: ref40 article-title: Energetics of peptide and protein binding to lipid membranes publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4419-6327-7_2 – volume: 21 start-page: 1 year: 2020 ident: ref4 article-title: A new era of antibiotics: the clinical potential of antimicrobial peptides publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21197047 – volume: 13 start-page: 35 year: 2021 ident: ref7 article-title: Molecular engineering of antimicrobial peptides: microbial targets, peptide motifs and translation opportunities publication-title: Biophys. Rev. doi: 10.1007/s12551-021-00784-y – volume: 263 start-page: 127152 year: 2022 ident: ref5 article-title: Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: a review publication-title: Microbiol. Res. doi: 10.1016/j.micres.2022.127152 – volume: 40 start-page: 481 year: 2011 ident: ref15 article-title: Using zeta-potential measurements to quantify peptide partition to lipid membranes publication-title: Eur. Biophys. J. doi: 10.1007/s00249-010-0661-4 – volume: 11 start-page: 443 year: 2022 ident: ref3 article-title: Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis publication-title: Emerg. Microbes Infect. doi: 10.1080/22221751.2022.2030196 – volume: 14 start-page: 32855 year: 2022 ident: ref16 article-title: Evaluation of the antimicrobial activity in host-mimicking media and in vivo toxicity of antimicrobial polymers as functional mimics of AMPs publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.2c05979 – volume: 61 start-page: e02097-16 year: 2017 ident: ref37 article-title: Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of Carbapenem-resistant Klebsiella pneumoniae infections publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.02097-16 – volume: 7 start-page: e897 year: 2022 ident: ref29 article-title: The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis publication-title: Lancet Public Health doi: 10.1016/S2468-2667(22)00225-0 – volume: 16 start-page: 7641 year: 2023 ident: ref1 article-title: Methicillin resistant Staphylococcus aureus: molecular mechanisms underlying drug resistance development and novel strategies to combat publication-title: Infect. Drug Resist. doi: 10.2147/IDR.S428103 – volume: 96 start-page: 9 year: 2019 ident: ref6 article-title: Fish-derived antimicrobial peptides: activity of a chionodracine mutant against bacterial models and human bacterial pathogens publication-title: Dev. Comp. Immunol. doi: 10.1016/j.dci.2019.02.012 – volume: 33 start-page: 300 year: 2017 ident: ref20 article-title: Action and resistance mechanisms of antibiotics: a guide for clinicians publication-title: J. Anaesthesiol. Clin. Pharmacol. doi: 10.4103/joacp.JOACP_349_15 – volume: 181 start-page: 106363 year: 2023 ident: ref26 article-title: Advancements, challenges and future perspectives on peptide-based drugs: focus on antimicrobial peptides publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2022.106363 – volume: 4 year: 2022 ident: ref28 article-title: Antimicrobial resistance: revisiting the mechanisms of resistance publication-title: Access Microbiol. doi: 10.1099/acmi.ac2021.po0053 – volume: 158 start-page: 105040 year: 2021 ident: ref17 article-title: Genetic basis of molecular mechanisms in β-lactam resistant gram-negative bacteria publication-title: Microb. Pathog. doi: 10.1016/j.micpath.2021.105040 – ident: ref13 – volume: 20 start-page: e216 year: 2020 ident: ref27 article-title: The value of antimicrobial peptides in the age of resistance publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(20)30327-3 – volume: 7 start-page: 220 year: 2024 ident: ref2 article-title: Unraveling the effects of cationic peptides on vesicle structures: insights into peptide-membrane interactions publication-title: ACS Appl. Bio Mater. doi: 10.1021/acsabm.3c00824 – volume: 14 start-page: 14 year: 2023 ident: ref8 article-title: A novel antimicrobial peptide screened by a Bacillus subtilis expression system, derived from Larimichthys crocea ferritin H, exerting bactericidal and parasiticidal activities publication-title: Front. Immunol. doi: 10.3389/fimmu.2023.1168517 – volume: 4 start-page: 419 year: 2013 ident: ref24 article-title: Galleria mellonella larvae as an infection model for group a streptococcus publication-title: Virulence doi: 10.4161/viru.24930 – volume: 27 start-page: 2675 year: 2022 ident: ref23 article-title: Antimicrobial mechanisms and clinical application prospects of antimicrobial peptides publication-title: Molecules doi: 10.3390/molecules27092675 – year: 2016 ident: ref32 – volume: 10 start-page: 10 year: 2020 ident: ref35 article-title: A how-to guide for mode of action analysis of antimicrobial peptides publication-title: Front. Cell Infect. Microbiol. doi: 10.3389/fcimb.2020.540898 – volume: 12 start-page: 12 year: 2022 ident: ref18 article-title: Global threat of Carbapenem-resistant gram-negative bacteria publication-title: Front. Cell Infect. Microbiol. doi: 10.3389/fcimb.2022.823684 – volume: 501 start-page: 146 year: 2001 ident: ref9 article-title: Optimization of the antimicrobial activity of magainin peptides by modification of charge publication-title: FEBS Lett. doi: 10.1016/S0014-5793(01)02648-5 – volume: 9 start-page: 66 year: 2020 ident: ref11 article-title: Trematocine, a novel antimicrobial peptide from the Antarctic fish Trematomus bernacchii: identification and biological activity publication-title: Antibiotics (Basel). doi: 10.3390/antibiotics9020066 – volume: 5 start-page: e00775-20 year: 2020 ident: ref31 article-title: A ceftazidime-avibactam-resistant and Carbapenem-susceptible Klebsiella pneumoniae strain harboring blaKPC-14 isolated in New York City publication-title: mSphere doi: 10.1128/mSphere.00775-20 – volume: 1866 start-page: 184260 year: 2024 ident: ref38 article-title: Tryptophan-and arginine-rich antimicrobial peptides: anti-infectives with great potential publication-title: Biochim. Biophys. Acta Biomembr. doi: 10.1016/j.bbamem.2023.184260 – volume: 65 start-page: 601 year: 2010 ident: ref36 article-title: Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/dkq037 – volume: 399 start-page: 629 year: 2022 ident: ref30 article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis publication-title: Lancet doi: 10.1016/S0140-6736(21)02724-0 – volume: 80 start-page: 374 year: 2012 ident: ref25 article-title: Prediction of protein secondary structure from circular dichroism using theoretically derived spectra publication-title: Proteins doi: 10.1002/prot.23188 – volume: 265 start-page: 116072 year: 2024 ident: ref19 article-title: Antimicrobial peptides: An alternative to traditional antibiotics publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2023.116072 – volume-title: WHO Bacterial Priority Pathogens List, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance [Internet] year: 2024 ident: ref39 – ident: ref14 |
SSID | ssj0000402000 |
Score | 2.3980992 |
Snippet | This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two... IntroductionThis study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1447301 |
SubjectTerms | antimicrobial peptides antimicrobial resistance ESKAPE pathogens membranolytic agents Microbiology multi-drug resistant bacteria |
SummonAdditionalLinks | – databaseName: Open Access Journals (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlEOiltEk_3CZBgd6KqWXZstzbJmwICS2FJpCb0CdraOwl9hbyK_KXOyM7y24J7aUngy2PxcyzNc-S3hDyEVJUgIa1qa0LnhahqlLNCp_C0OBykTvHBW5w_vpNnF8XFzflzUapL1wTNsoDj477nPnSay95qEtb6GCNk4XLdMhqyY3Vka3DmLdBpuI3GGlRlo27ZICF1RCmxhrgg3mB85mI662RKAr2P5Vl_rlYcmP0OXtJXkxpI52N3X1Fnvl2j-yOhSTv98nD1R1qr3Y4S546ANUv7yj4rLltotAS3LrE5SvO9xQ3lFBI--isHQDlYJCGpl_QycTtqqcGfxJau9BN84UuO0irh2jNjNLOYE3jjqweDrqB_JLOf1zOvs8pljfu4Er_mlyfza9Oz9Op1EJqgR8PqZdaG2OlC05A9LiWsoRMhgc466ogSgdOFLmVwgKNLW1tcmErW2Qe5Xt8zd-QnbZr_TtCeV5pUWqmBfMQe29MxXTgwlQiyMBEQtij25WddMixHMZPBXwEQ6ViqBSGSk2hSsin9T3LUYXjr61PMJrrlqigHU8ArtSEK_UvXCXk-BELCt44nEbRre9WveKo3SghL5UJeTtiY_0oDuyXASlNiNxCzVZftq-0zSKqejPGOdgt3_-P3n8gz9EjcaVidUB2hruVP4TsaTBH8UX5DTOsHgs priority: 102 providerName: Directory of Open Access Journals |
Title | Trematocine-derived antimicrobial peptides from the Antarctic fish Trematomus bernacchaii: potent antibacterial agents against ESKAPE pathogens |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39171261 https://www.proquest.com/docview/3095681058 https://pubmed.ncbi.nlm.nih.gov/PMC11335685 https://doaj.org/article/0e5eae83f95c4afcbd84d0af0983bca0 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ti9NAEF7OE-W-iO_Gl2MFv0kkm002G0GkSs9DORG8Qr-Ffb0G7pLapOL9C3-yM5u0WLnzSwt5maQ7M51ndneeIeQVQFQwDWNiU2Y8znxRxIplLobQYFORWssFFjiffBXHs-zzPJ_vkU27o3EAuytTO-wnNVudv_n14_I9OPw7zDgh3oIGaqMh1UszXKpEk71BbkJkKrCjwckI98M_MyZLoSqFCYELAul8qKO5RswBuc0hnWGpYDthK7D7XwVJ_91Z-VeoOrpL7owYk04Go7hH9lxzn9wauk5ePiC_T1dI1NriknpswQJ_OkthgOuLOrAywa1L3OtiXUex-oQCRqSTpgeXAIHU192CjiIu1h3VOKNozELVNX1Lly2A8D6I0wMRNIhTWL_VwZeqAY3S6fcvk29Tis2QWzjTPSSzo-npx-N4bMwQG8im-9hJpbQ20norQNdcSZkD7uEejtrCi9zCgIrUSGEg6c1NqVNhCpMlDsl-XMkfkf2mbdwTQnlaKJErpgRzYClO64Ipz4UuhJeeiYiwzbhXZmQtx-YZ5xVkL6i2KqitQrVVo9oi8np7z3Lg7Pjv1R9QndsrkW87HGhXZ9XovlXicqec5L7MTaa80VZmNlE-KSXXRiURebkxhgr8ExddVOPadVdxZHqUgGJlRB4PxrF91Ma4IiJ3zGbnXXbPNPUicIAzxjnIzZ9eK_QZOcCfGTYrFs_Jfr9auxcAoHp9GCYe4PPTnB0GD_kDtDsbYw |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trematocine-derived+antimicrobial+peptides+from+the+Antarctic+fish+Trematomus+bernacchaii+%3A+potent+antibacterial+agents+against+ESKAPE+pathogens&rft.jtitle=Frontiers+in+microbiology&rft.au=Squitieri%2C+Damiano&rft.au=Massaro%2C+Federica&rft.au=Graziano%2C+Monica+Mollica&rft.au=Borocci%2C+Stefano&rft.date=2024-08-07&rft.issn=1664-302X&rft.eissn=1664-302X&rft.volume=15&rft.spage=1447301&rft_id=info:doi/10.3389%2Ffmicb.2024.1447301&rft_id=info%3Apmid%2F39171261&rft.externalDocID=39171261 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon |